阿帕替尼治疗转移性结肠癌1例

图 1 升结肠肿瘤变化情况

Figure 1. The changes of colonic cancer

A. The condition of colon tumor before the treatment; B. Colon cancer significantly reduced after treatment

下载: 全尺寸图片幻灯片

图 2 肝转移灶变化情况

Figure 2. The change of liver metastasis

A. Liver metastasis; B. The liver metastatic lesion was smaller than that before the treatment; C. Liver lesion was not obviously enhanced

下载: 全尺寸图片幻灯片

图 3 肺转移灶变化情况

Figure 3. The change of pulmonary metastasis

A. Left pulmonary metastasis nodule; B. No change in left pulmonary metastasis nodules; C.No change in left pulmonary metastasis nodules

下载: 全尺寸图片幻灯片

[1]	Van Cutsem E, Costa F.Progress in the adjuvant treatment of colon Cancer:has it influenced clinical practice[J].JAMA, 2005, 294(21):2758-2760. doi: 10.1001/jama.294.21.2758
[2]	Weitz J, Koch M, Debus J, et al.Colorectal cancer[J].Lancet, 2005, 365(9454):153-165. doi: 10.1016/S0140-6736(05)17706-X
[3]	Li J, Qin S, Xu J, et al.Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phaseⅡtrial[J].J Clin Oncol, 2013, 31(26):3219-3225. doi: 10.1200/JCO.2013.48.8585
[4]	Li J, Zhao X, Chen L, et al.Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies[J].BMC Cancer, 2010, 10(1):529. doi: 10.1186/1471-2407-10-529